Our Team | Third Arc Bio

Our team has collectively brought over 35 drug approvals, including multiple therapies that have redefined the standard of care in oncology in immunology & inflammation.

Third Arc Bio’s multispecific antibodies in light and dark green and light and dark blue against a white background.

We have demonstrated a proven track record of:

Light blue DNA double helix

Cricle Gradient Shape

Leading the very best multidisciplinary research teams with relentless execution to deliver breakthrough treatments for challenging disease

Light blue abstract arrow and circle shape

Cricle Gradient Shape

Coupling actionable science with advanced biologics engineering methods to create transformational therapeutics

Light blue antibody

Cricle Gradient Shape

Seamlessly navigating an end-to-end drug development process with speed and high quality

Peter F. Lebowitz, MD, PhD

Chief Executive Officer and Chief Medical Officer

Sanjaya Singh, PhD

Founder and Chief Scientific Officer

Joe Erhardt, PhD

Chief Research and Development Officer

Debi Watson

Chief Business and Operations Officer

Raj Ganesan, PhD

Vice President, Antibody and Protein Engineering

Natalie Hutnick, PhD

Vice President, Head of Project Leadership, Oncology

Michael Liao, PhD

Vice President, Clinical Pharmacology

Theresa McDevitt, PhD

Vice President, Head of Oncological Research

Danlin Y. McGowan, PhD

Vice President, Discovery and CMC Strategies and Operations

Carrie Saulsbery, PhD

Vice President, Head of Immunology

Arvind Srivastava, PhD

Senior Vice President, Chemistry, Manufacturing, and Controls

Michael Streit, MD

Executive Vice President, Clinical Development

Jen Teti

Vice President, Clinical Operations

Our Investment Partners

Abstract lime green geometric mesh pattern on a navy blue background.

Abstract lime green geometric mesh pattern on a navy blue background.